Skip to content

Author

Stephanie Elbanna

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Case report Open access Sep 2026

Radiation Dose Reduction in Coronary Computed Tomography Angiography: A Reproducibility and Expansion Study.

BACKGROUND Limiting the harms of ionizing radiation using dose reduction techniques in coronary computed tomography angiography (CCTA) is paramount in evaluating coronary artery disease. PROJECT RATIONALE Assess the reproducibility of a CCTA radiation dose reduction strategy using patient-centric standardized compute...

E. Odigie-Okon, O. Ogunleye, Ritika Saxena et al. · 0 citations
Open access Oct 2026

Comparative Effectiveness of Direct Oral Anticoagulants Versus Warfarin in Cardiac Amyloidosis With Non-Valvular Atrial Fibrillation: A Propensity-Matched Analysis

Anticoagulation is recommended for atrial fibrillation (AF) in cardiac amyloidosis regardless of CHA₂DS₂-VASc score, but no guidance exists on agent selection. Using the TriNetX Research Network, we identified adults with amyloidosis (ICD-10 E85) and non-valvular AF/flutter (I48). Prosthetic valves and rheumatic mitral...

James Rice, Stephanie Elbanna, Yumna Furqan et al. · 0 citations
Aug 2026

Comparative Effectiveness and Outcomes of Direct Oral Anticoagulants vs. Vitamin K Antagonists (VKA) in Atrial Arrhythmias Patients with Isolated Lupus Anticoagulant Without Antiphospholipid Syndrome: A Real-World Cohort Analysis.

BACKGROUND Direct oral anticoagulants (DOACs) are preferred over VKA for stroke prevention in atrial fibrillation/flutter (AF), but concerns exist regarding their use in antiphospholipid syndrome (APS). The safety and effectiveness of DOACs in AF patients with isolated lupus anticoagulant (LA) who do not meet APS crite...

Omar Obeidat, Laith Alhuneafat, Mohamed F. Ismail et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.